您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > DX3-213B
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
DX3-213B
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
DX3-213B图片
CAS NO:2749555-66-4
包装与价格:
包装价格(元)
1mg电议
5mg电议
10mg电议

产品介绍
DX3-213B 是一种高效的、具有口服活性的氧化磷酸化 (OXPHOS) 复合物 I 抑制剂 (IC50=3.6 nM)。 DX3-213B 抑制 ATP 生成 (IC50=11 nM),并阻止 MIA PaCa-2 细胞生长 (GI50=11 nM)。 DX3-213B 用于胰腺癌的研究。
Cas No.2749555-66-4
Canonical SMILESO=S(N1C[C@@H](CCC1)C(N2CCC(F)(CC2)F)=O)(C3=CC=C(C=C3)S(C(C)C)(=O)=O)=O
分子式C20H28F2N2O5S2
分子量478.6
溶解度DMF: 2 mg/ml,DMSO: 3 mg/ml,Ethanol: 2 mg/ml,PBS (pH 7.2): insol
储存条件-20°C
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

DX3-213B is an inhibitor of mitochondrial complex I, also known as NADH dehydrogenase (IC50= 3.6 nM).1It inhibits the proliferation of MiaPaCa-2 cells cultured in galactose- but not glucose-containing media (IC50s = 9.1 and >3,000 nM, respectively). DX3-213B (10 mg/kg) reduces tumor volume in a Panc02 murine pancreatic ductal adenocarcinoma model.

1.Xue, D., Xu, Y., Kyani, A., et al.Multiparameter optimization of oxidative phosphorylation inhibitors for the treatment of pancreatic cancerJ. Med. Chem.65(4)3404-3419(2022)